RTX Q3 Preview: Two Growth Engines Make This Aerospace And Defense Leader A 'Buy'

RTX reported Q2 2026 sales growth of 14% and EPS growth of 21%, while upgraded sales and earnings guidance is supported by a $289 billion backlog, including $119 billion in defense. The article maintains a Buy view, citing recent defense contracts, commercial aerospace aftermarket growth and improving operations.

Analysis

The key underwriting question is conversion, not headline backlog size: contracts and aftermarket demand create value only if RTX can deliver on schedule, protect segment margins, and turn earnings into cash. A larger defense mix may improve demand visibility but does not eliminate funding, procurement-timing, or fixed-price execution risk. Commercial aftermarket growth is also sensitive to airline utilization and shop capacity; bottlenecks can defer revenue even when demand is firm.

Near term, the optimistic framing may support sentiment, but the article provides no valuation, free-cash-flow, or segment-margin detail to justify chasing the shares. Over the next 1–3 months, test the thesis against organic growth, margin progression, cash conversion, and guidance changes—not EPS growth alone. Over 6–18 months, execution on the Pratt & Whitney GTF inspection/remediation burden remains a material swing factor: progress could release capacity and reduce uncertainty; renewed disruption could absorb resources and offset commercial upside. Defense awards likewise need to translate into funded, profitable work.

Contrarian point: backlog can be mistaken for near-term earnings certainty. The market may be underweight conversion and execution risks, while a broad downturn in airline utilization or slower defense appropriations could weaken the two growth engines at once. Without current valuation and cash-flow data, the signal supports monitoring rather than an unconditional Buy.

Key Decisions for Investors

• Do not add solely on the backlog or reported EPS growth. Before increasing exposure, verify the latest organic sales and segment-margin trends, free-cash-flow conversion, and whether guidance upgrades are supported by cash generation.
• For existing RTX exposure, retain a constructive bias but size around execution risk. Reassess if quarterly cash conversion disappoints, segment margins retreat, or management cuts delivery or earnings expectations.
• Watch the next 1–3 months for GTF remediation cadence and defense contract funding/conversion. A material improvement in both would strengthen the thesis; renewed engine disruption or delayed appropriations would weaken it.
• A relative-value long RTX versus a broad aerospace-and-defense basket is only a conditional idea if RTX estimate revisions improve without a valuation premium widening materially; check current relative valuation and consensus revisions first. No price target or outright add is warranted from the supplied information.